Patient guides
Stem Cell Therapy: Evidence & Approval Explained
A practical way to distinguish established care, regulated research and clinic marketing.
An advertised service is not proof of effectiveness or regulatory approval. Approval applies to a particular product, indication and jurisdiction—not to every procedure that uses the words “stem cell”.
Three different kinds of claim
Established treatment: an intervention supported for a defined medical use. Blood-forming stem cell transplantation is used for selected cancers and blood disorders. This is a specialist treatment pathway and is not equivalent to a general wellness infusion.
Investigational treatment: an intervention being studied under a specific protocol. Ask for the study identifier, responsible investigator, ethics review and regulatory authorization. A trial listing alone does not establish approval.
Clinic marketing: a provider’s description of what it sells or hopes to achieve. Testimonials, equipment photographs and before-and-after images do not establish comparative effectiveness.
Check the exact product and purpose
Ask for the product name, cell source, processing method, administration route and intended indication in writing. Then ask which authority permits that exact use in South Korea and for the relevant documentation. Institutional registration, a device certificate and a product authorization answer different questions.
Approval can be narrow. The US FDA lists Ryoncil for steroid-refractory acute graft-versus-host disease in pediatric patients aged two months and older. That does not authorize an unrelated anti-aging infusion. MEDIPOST reports Korean approval of Cartistem for specified knee cartilage defects; that does not establish approval for every knee cell injection.
Read research without overextending it
Match the study to the proposed procedure. The participants’ diagnosis, the cells used, dose, route, comparator and follow-up all matter. A result from a different product or a small uncontrolled study may not answer your question.
Ask about meaningful improvement, adverse events and how long any effect lasted. A laboratory finding is not a patient outcome. If a clinic cannot provide a study matching its service, record that uncertainty instead of assuming evidence transfers.
Sources and further reading
- National Cancer Institute — Stem cell transplants in cancer treatmentSource checked 9 October 2026.
- US FDA — Ryoncil product informationSource checked 9 October 2026.
- MEDIPOST — Cartistem product information (manufacturer)Source checked 9 October 2026.
- ASGCT — Unproven stem cell productsSource checked 9 October 2026.